Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DBCAT003826Pharmacologic class
Source: Volpi-abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. A DrugBank category of 194 drugs. 144 of them are approved.
- Also known as
- Serotonin Syndrome
- Drugs
- 2,5-Dimethoxy-4-ethylamphetamine
- 2,5-Dimethoxy-4-ethylthioamphetamine
- 5-methoxy-N,N-dimethyltryptamine
- Alaproclate
- Alfentanil
- Almotriptan
- Alphacetylmethadol
- Alphaprodine
- Amantadine
- Amitriptyline
- Amitriptylinoxide
- Amoxapine
- Amphetamine
- Aripiprazole
- Aripiprazole lauroxil
- Benmoxin
- Benzphetamine
- Bezitramide
- Bifemelane
- Brofaromine
- Brolamfetamine
- Buprenorphine
- Buspirone
- Butorphanol
- Butriptyline
What you can answer from here — as of August 13, 2018
Which targets do Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account